1.395

1.06% -0.015

Pre-market: 1.38 -0.015 -1.08%

Canopy Growth Corporation (CGC)

Overview News Price History Option Chain Why CGC Down? Discussions Forecast

Canopy Growth Corporation stock is traded at $1.395, with a volume of 9.20M. It is down -1.06% in the last 24 hours and down -29.90% over the past month. Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Previous Close:

$1.41

Open:

$1.4

24h Volume:

9.20M

Relative Volume:

1.33

Market Cap:

$205.23M

Revenue:

$211.87M

Net Income/Loss:

$-551.61M

P/E Ratio:

-0.2044

EPS:

-6.8241

Net Cash Flow:

$-140.45M

1W Performance:

-14.42%

1M Performance:

-29.90%

6M Performance:

-73.22%

1Y Performance:

-57.60%

1-Day Range:

$1.36

$1.42

1-Week Range:

$1.36

$1.67

52-Week Range:

$1.36

$14.92

Canopy Growth Corporation Stock (CGC) Company Profile

Name

Canopy Growth Corporation

Sector

Healthcare (1169)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

855-558-9333

Address

1 Hershey Drive, Smiths Falls, ON

Employee

2,000

Twitter

@CanopyGrowth

Next Earnings Date

2025-02-07

Latest SEC Filings

CGC's Discussions on Twitter

Compare CGC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CGC Canopy Growth Corporation	1.395	205.23M	211.87M	-551.61M	-140.45M	-6.8241
ZTS Zoetis Inc	167.24	74.89B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.18	46.03B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.41	45.69B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.46	18.86B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	128.20	13.63B	612.78M	-86.37M	-62.91M	-0.87

Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-04-23	Upgrade	Bernstein	Underperform → Mkt Perform
Nov-02-22	Initiated	Bernstein	Underperform
Oct-26-22	Upgrade	Canaccord Genuity	Sell → Hold
Jun-08-22	Downgrade	BMO Capital Markets	Market Perform → Underperform
Mar-22-22	Downgrade	Barclays	Equal Weight → Underweight
Dec-22-21	Downgrade	BofA Securities	Neutral → Underperform
Dec-20-21	Downgrade	Piper Sandler	Neutral → Underweight
Dec-07-21	Initiated	Wells Fargo	Underweight
Nov-18-21	Initiated	Barclays	Equal Weight
Nov-08-21	Downgrade	CIBC	Neutral → Sector Underperform
Nov-08-21	Downgrade	Canaccord Genuity	Hold → Sell
Nov-08-21	Downgrade	Cowen	Outperform → Market Perform
Oct-01-21	Downgrade	BofA Securities	Buy → Neutral
Aug-12-21	Upgrade	Jefferies	Underperform → Hold
Jun-02-21	Upgrade	Canaccord Genuity	Sell → Hold
May-25-21	Upgrade	MKM Partners	Neutral → Buy
Apr-28-21	Resumed	BofA Securities	Buy
Feb-24-21	Downgrade	Jefferies	Hold → Underperform
Feb-10-21	Downgrade	Canaccord Genuity	Hold → Sell
Feb-10-21	Downgrade	The Benchmark Company	Buy → Hold
Feb-05-21	Downgrade	Piper Sandler	Overweight → Neutral
Sep-04-20	Upgrade	CFRA	Buy → Strong Buy
Jun-01-20	Downgrade	BMO Capital Markets	Outperform → Market Perform
Jun-01-20	Downgrade	Bryan Garnier	Neutral → Sell
Jun-01-20	Downgrade	CIBC	Sector Outperform → Neutral
Jun-01-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Jun-01-20	Downgrade	Stifel	Buy → Sell
May-22-20	Resumed	BofA/Merrill	Buy
Apr-16-20	Upgrade	Jefferies	Underperform → Hold
Jan-28-20	Upgrade	BMO Capital Markets	Market Perform → Outperform
Dec-12-19	Reiterated	Cantor Fitzgerald	Neutral
Nov-20-19	Upgrade	BofA/Merrill	Neutral → Buy
Nov-15-19	Downgrade	Alliance Global Partners	Buy → Neutral
Nov-05-19	Initiated	Cantor Fitzgerald	Neutral
Oct-14-19	Downgrade	Seaport Global Securities	Buy → Neutral
Oct-11-19	Downgrade	Jefferies	Hold → Underperform
Sep-27-19	Downgrade	BofA/Merrill	Buy → Neutral
Sep-20-19	Initiated	MKM Partners	Neutral
Sep-18-19	Initiated	Oppenheimer	Perform
Aug-26-19	Upgrade	Seaport Global Securities	Neutral → Buy
Jul-17-19	Initiated	Ladenburg Thalmann	Buy

View All

Canopy Growth Corporation Stock (CGC) Latest News

Mar 02, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive

Mar 02, 2025

This Week In Cannabis: Big Earnings Reports, Ice Cube's New Brand, Trump's Mixed Signals, Germany's Import Boom And Much More - Benzinga India

Mar 02, 2025

Feb 28, 2025

Canopy Growth to issue $200 million in new stock shares - Green Market Report

Feb 28, 2025

Canopy Growth Launches US$200 Million Equity Program to Strengthen Financial Position - TipRanks

Feb 28, 2025

Canopy Growth establishes new $200M at-the-market equity program - TipRanks

Feb 28, 2025

Will Canopy Growth's New $200M Equity Raise Dilute Shareholders or Strengthen Its Future? - StockTitan

Feb 28, 2025

Feb 27, 2025

Germany's Cannabis Imports Increase 4x In 2024 Amid Regulatory Changes: Which Countries Are Top Providers? - Benzinga

Feb 27, 2025

Canopy announces launch of its Tweed brand in German medical cannabis market - StratCann

Feb 27, 2025

Stocks in play: Canopy Growth Corporation - The Globe and Mail

Feb 27, 2025

Canopy Growth expands Tweed brand in Germany | 2025-02-27 | Investing News - Stockhouse Publishing

Feb 27, 2025

Canopy Growth Corporation - Baystreet.ca

Feb 27, 2025